<p class="MsoNormal"> Opportunities exist for clinical decision support (CDS) to help transplant nephrologists counsel living donors receiving APOL1 genetic test results. A new Kidney360 study provides insights from transplant nephrologists on how this CDS should be developed.</p>

Opportunities exist for clinical decision support (CDS) to help transplant nephrologists counsel living donors receiving APOL1 genetic test results. A new Kidney360 study provides insights from transplant nephrologists on how this CDS should be developed.

<p> Opportunities exist for clinical decision support (CDS) to help transplant nephrologists counsel living donors receiving APOL1 genetic test results. A new Kidney360 study provides insights from transplant nephrologists on how this CDS should be developed.</p>

Transplant Nephrologists' Preferences for Clinical Decision Support for APOL1 Genetic Testing: A Focus Group Study

Kidney360 is ASN's first open access, online only, general kidney journal that includes content from all disciplines of kidney science. Published content includes both clinical and basic science papers. Kidney360 promises to bring you the same high-quality peer-review you've come to expect from ASN's publications. Check out our podcasts released this year and hear directly from the authors and patients.

Share Transplant Nephrologists' Preferences for Clinical Decision Support for APOL1 Genetic Testing: A Focus Group Study

Sign up to save your podcasts

Transplant Nephrologists' Preferences for Clinical Decision Support for APOL1 Genetic Testing: A Focus Group Study

Transplant Nephrologists' Preferences for Clinical Decision Support for APOL1 Genetic Testing: A Focus Group Study